How to Buy Pliant Therapeutics Stock

Pliant Therapeutics Inc

Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States.

Pliant Therapeutics stock last closed at $1.14, up 1.33% from the previous day, and has decreased 21.92% in one year. It has overperformed other stocks in the Biotechnology industry by 0.01 percentage points. Pliant Therapeutics stock is currently +11.76% from its 52-week low of $1.02, and -41.54% from its 52-week high of $1.95.

There are currently 61.92M PLRX shares outstanding. The market capitalization of PLRX is $70.59M. In the past 24 hours, 398,000 PLRX shares were traded.

How to Buy Pliant Therapeutics Stock

Wondering how to invest in Pliant Therapeutics stock? Here's how.

  1. Decide where to buy Pliant Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Pliant Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Put funds into your investment account: Select your payment method and add your information.
  4. Evaluate Pliant Therapeutics stock: The Pliant Therapeutics ticker symbol is PLRX. Is Pliant Therapeutics stock a good investment? Should you buy shares of PLRX? How do PLRX's underlying business fundamentals look? Do top analysts think Pliant Therapeutics is a good buy? Why has PLRX's stock price moved recently? (Hint: Our stock market analysis website can help you understand if PLRX is a good stock to buy).
  5. Execute your PLRX buy order: Decide if you will purchase PLRX shares at the current market price or use a limit order to purchase PLRX shares at a given price.
  6. Get the latest scoop on your investment in PLRX: Create a watchlist to important updates regarding your new investment in Pliant Therapeutics shares.

Step 1: Decide where to buy Pliant Therapeutics stock

You will need a brokerage account in order to access the NASDAQ market and buy PLRX shares.

A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best place to buy stocks. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to world markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected the right brokerage, you need to fill out some personal details so you are able to buy PLRX stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to start your new trading account.
  1. Submit your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you have created your account on the best app for stock investing, you can securely and quickly fund your account:

Check out the video below to see the process of transferring funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Pliant Therapeutics stock

After you have decided on the best place to buy Pliant Therapeutics stock, it's absolutely critical to research their stock before you invest, so you can wrap your head around the risk and opportunity.

Overview of key PLRX info

PLRX Price
$1.14
1w %
0.88%
1y %
-21.92%
5y %
-93.55%
P/E
-0.77x
P/B
0.48x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$92.29M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$70.59M
Next Earnings
Nov 5, 2026
Next Dividend
N/A

Fundamentals of PLRX

WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis.

You can see all of the due diligence checks on PLRX's stock page.

Is PLRX stock undervalued?

Investors use many financial metrics, analyses, models, and charts to gauge PLRX's intrinsic value.

Using relative valuations methods:

  • PLRX may be undervalued based on its P/B ratio of 0.48x, relative to Biotechnology industry P/B ratio of 5.21x

You can do more valuation research on PLRX's stock here.

PLRX Financial Health

Signs that PLRX is financially healthy:

  • There are more short-term assets than long-term liabilities on the PLRX balance sheet.
  • PLRX has a low debt to equity ratio of 0.29.
  • PLRX has $159.58M in cash and short term investments. This is sufficient to cover its annual cash burn of $70.62M.
  • PLRX has cash burn of 70621000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the PLRX balance sheet.

Signs that PLRX is not financially healthy:

  • Total PLRX debt is higher than 5 years ago, relative to shareholder equity.

You can dig deeper into what analysts are forecasting on the Pliant Therapeutics stock forecast page.

Metrics for Advanced PLRX Traders

SMA10
1.13
SMA20
1.13
SMA50
1.11
SMA100
1.14
SMA200
1.2
MACD
0
MACD Signal
0
MACD Histogram
0
RSI
52.31
Stochastic %K
56.52
Stochastic %D
49.28
StochRSI %K
64.62
StochRSI %D
56.32

How are PLRX Revenues/Earnings doing?

Last year, PLRX revenue was $0.00. Over the last five year, PLRX's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 31.91%.

Learn more about PLRX's earnings and revenue performance here.

What are PLRX executives and large shareholders up to?

In the last year, executives and large shareholders at PLRX have sold more shares than they have bought.

Lily Cheung, Chief Human Resource Officer of PLRX, was the latest PLRX insider to sell. They sold $9,643.52 worth of PLRX stock on Jan 20, 2026.

Get more info about who owns PLRX stock here.

Does PLRX stock generate passive income?

No, Pliant Therapeutics doesn't provide an income stream by paying out dividends.

Get analysis from other investors

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Execute your PLRX buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are mostly fine.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific price, place a limit order.

Click the Open button and eToro will execute your order.

If you want additional assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest scoop on your investment in PLRX

Now that you own some PLRX shares, you'll want to keep up with your new stock purchase.

Add PLRX to a watchlist to track your PLRX stock.

PLRX Feed

How to Buy Stock in Pliant Therapeutics

To summarize, here are the 6 steps to buy Pliant Therapeutics stock:

  1. Decide where to buy Pliant Therapeutics stock
  2. Open your brokerage account
  3. Put funds into your investment account
  4. Evaluate Pliant Therapeutics stock
  5. Execute your PLRX buy order
  6. Get the latest scoop on your investment in PLRX

If you need a brokerage account, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your investment in Pliant Therapeutics, create your watchlist below.

NASDAQ: PLRX
$1.14+0.02 (+1.33%)
Updated Sep 24, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: PLRX
$1.14+0.02 (+1.33%)
Updated Sep 24, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Pliant Therapeutics share?

As of Sep 24, 2026, it costs $1.14 to buy one share of Pliant Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.57, you can buy 0.5 shares of PLRX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Pliant Therapeutics stock?

One way to place an order for Pliant Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.